Evidence map›Paper›PMID 35771990›Full record

ArticleDiabetes2022

Heterogeneous Development of β-Cell Populations in Diabetes-Resistant and -Susceptible Mice.

Pascal Gottmann, Thilo Speckmann, Mandy Stadion, Erika Zuljan, Heja Aga, Michael Sterr, Maren Büttner, Patrícia Martínez Santos, Markus Jähnert, Stefan R Bornstein and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Editorial: Pancreatic beta-cell dedifferentiation.Frontiers in endocrinology · 2024
    Article
  9. Article
  10. Identification of Novel Genes Involved in Hyperglycemia in Mice.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Pascal GottmannDepartment of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.ORCID 0000-0002-9791-783X
Thilo SpeckmannDepartment of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
Mandy StadionDepartment of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
Erika ZuljanDepartment of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
Heja AgaDepartment of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
Michael SterrGerman Center for Diabetes Research (DZD), Neuherberg, Germany.
Maren BüttnerGerman Center for Diabetes Research (DZD), Neuherberg, Germany.
Patrícia Martínez SantosDepartment of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
Markus JähnertDepartment of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
Stefan R BornsteinDepartment of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
Fabian J TheisInstitute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany.
Heiko LickertGerman Center for Diabetes Research (DZD), Neuherberg, Germany.
Annette SchürmannDepartment of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.ORCID 0000-0002-4113-4377
Deutsches Diabetes-Zentrum e.V. · DEHelmholtz Zentrum München · DEGerman Institute of Human Nutrition · DEKing's College London · GBUniversity of Potsdam · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progressive dysfunction and failure of insulin-releasing β-cells are a hallmark of type 2 diabetes (T2D). To study mechanisms of β-cell loss in T2D, we performed islet single-cell RNA sequencing of two obese mouse strains differing in their diabetes susceptibility. With mice on a control diet, we identified six β-cell clusters with similar abundance in both strains. However, after feeding of a diabetogenic diet for 2 days, β-cell cluster composition markedly differed between strains. Islets of diabetes-resistant mice developed into a protective β-cell cluster (Beta4), whereas those of diabetes-prone mice progressed toward stress-related clusters with a strikingly different expression pattern. Interestingly, the protective cluster showed indications of reduced β-cell identity, such as downregulation of GLUT2, GLP1R, and MafA, and in vitro knockdown of GLUT2 in β-cells-mimicking its phenotype-decreased stress response and apoptosis. This might explain enhanced β-cell survival of diabetes-resistant islets. In contrast, β-cells of diabetes-prone mice responded with expression changes indicating metabolic pressure and endoplasmic reticulum stress, presumably leading to later β-cell loss. In conclusion, failure of diabetes-prone mice to adapt gene expression toward a more dedifferentiated state in response to rising blood glucose levels leads to β-cell failure and diabetes development.

Indexed as

Diabetes Mellitus, Type 2Insulin-Secreting CellsIslets of LangerhansAnimalsApoptosisDisease SusceptibilityInsulinMiceMice, ObeseInsulin

Identifiers

PMID35771990
PMCPMC9862397
OpenAlexW4283725980

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.